SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-043390
Filing Date
2022-08-01
Accepted
2022-08-01 16:01:03
Documents
55
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0622_silopharma.htm   iXBRL 10-Q 789412
2 CERTIFICATION f10q0622ex31-1_silopharma.htm EX-31.1 15546
3 CERTIFICATION f10q0622ex32-1_silopharma.htm EX-32.1 4571
  Complete submission text file 0001213900-22-043390.txt   4892718

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE silo-20220630.xsd EX-101.SCH 77833
5 XBRL CALCULATION FILE silo-20220630_cal.xml EX-101.CAL 29134
6 XBRL DEFINITION FILE silo-20220630_def.xml EX-101.DEF 262297
7 XBRL LABEL FILE silo-20220630_lab.xml EX-101.LAB 591791
8 XBRL PRESENTATION FILE silo-20220630_pre.xml EX-101.PRE 276528
49 EXTRACTED XBRL INSTANCE DOCUMENT f10q0622_silopharma_htm.xml XML 473010
Mailing Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632
Business Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632 (718) 400-9031
Silo Pharma, Inc. (Filer) CIK: 0001514183 (see all company filings)

IRS No.: 462137136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54872 | Film No.: 221124681
SIC: 2300 Apparel & Other Finishd Prods of Fabrics & Similar Matl